| Naugatuck Valley Gastroenterology Consultants Llc | |
|
1312 W Main St Suite 101 Waterbury CT 06708-3121 | |
| (203) 756-6422 | |
| (203) 756-2448 |
| Full Name | Naugatuck Valley Gastroenterology Consultants Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1312 W Main St, Waterbury, Connecticut |
| Authorized Official Name and Position | Eileen S Paradis (ADMINISTRATOR) |
| Authorized Official Contact | 2037566422 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Naugatuck Valley Gastroenterology Consultants Llc 1312 W Main St Suite 101 Waterbury CT 06708-3121 Ph: (203) 756-6422 | Naugatuck Valley Gastroenterology Consultants Llc 1312 W Main St Suite 101 Waterbury CT 06708-3121 Ph: (203) 756-6422 |
| NPI Number | 1144350141 |
|---|---|
| Provider Enumeration Date | 03/07/2007 |
| Last Update Date | 02/21/2014 |
| Medicare PECOS PAC ID | 5092700575 |
|---|---|
| Medicare Enrollment ID | O20040415000308 |
News Archive
Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a portable, non-invasive monitor that can determine, in one minute and without drawing blood, whether chemotherapy patients have a reduced number of white blood cells that could lead to infections.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
As exposure to community violence increases for adolescent men of color, symptoms of depression subside and violent behaviors increase, according to new research published in the Journal of Clinical Child & Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144350141 | NPI | - | NPPES |
| 004146777 | Medicaid | CT | |
| CK2200 | Other | CT | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Robert Irwin Leventhal |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1275506214 PECOS PAC ID: 1951396449 Enrollment ID: I20040611000612 |
News Archive
Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a portable, non-invasive monitor that can determine, in one minute and without drawing blood, whether chemotherapy patients have a reduced number of white blood cells that could lead to infections.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
As exposure to community violence increases for adolescent men of color, symptoms of depression subside and violent behaviors increase, according to new research published in the Journal of Clinical Child & Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
› Verified 6 days ago
| Provider Name | Thomas A Rockoff |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1356313944 PECOS PAC ID: 3971586694 Enrollment ID: I20040611001019 |
News Archive
Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a portable, non-invasive monitor that can determine, in one minute and without drawing blood, whether chemotherapy patients have a reduced number of white blood cells that could lead to infections.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
As exposure to community violence increases for adolescent men of color, symptoms of depression subside and violent behaviors increase, according to new research published in the Journal of Clinical Child & Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
› Verified 6 days ago
| Provider Name | Anthony Schore |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1861538431 PECOS PAC ID: 7315027133 Enrollment ID: I20090625000629 |
News Archive
Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a portable, non-invasive monitor that can determine, in one minute and without drawing blood, whether chemotherapy patients have a reduced number of white blood cells that could lead to infections.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
As exposure to community violence increases for adolescent men of color, symptoms of depression subside and violent behaviors increase, according to new research published in the Journal of Clinical Child & Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
› Verified 6 days ago
| Provider Name | Raymond L Clement |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1114974078 PECOS PAC ID: 9931387750 Enrollment ID: I20110627000596 |
News Archive
Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a portable, non-invasive monitor that can determine, in one minute and without drawing blood, whether chemotherapy patients have a reduced number of white blood cells that could lead to infections.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
As exposure to community violence increases for adolescent men of color, symptoms of depression subside and violent behaviors increase, according to new research published in the Journal of Clinical Child & Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
› Verified 6 days ago
News Archive
Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a portable, non-invasive monitor that can determine, in one minute and without drawing blood, whether chemotherapy patients have a reduced number of white blood cells that could lead to infections.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
As exposure to community violence increases for adolescent men of color, symptoms of depression subside and violent behaviors increase, according to new research published in the Journal of Clinical Child & Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
› Verified 6 days ago
Hospitalist Physicians Of Connecticut Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 64 Robbins St, Waterbury, CT 06708 Phone: 203-573-6000 | |
Ionut Anton M.d. Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 171 Grandview Ave, Suite 204, Waterbury, CT 06708 Phone: 203-596-1906 Fax: 203-596-1861 | |
Staywell Health Care Inc/g.w. Mental/auth Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 95 Thomaston Ave, Waterbury, CT 06702 Phone: 203-756-8021 Fax: 203-805-4913 | |
Westside Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 714 Chase Parkway, Suite 6, Waterbury, CT 06708 Phone: 203-755-4577 Fax: 203-756-3628 | |
Digestive Disease Center Of Ct Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 60 Westwood Ave, Suite 314, Waterbury, CT 06708 Phone: 203-574-3007 Fax: 203-573-1739 | |
Paolo Mapelli Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1312 W Main St, Suite 101, Waterbury, CT 06708 Phone: 203-756-6422 Fax: 203-575-0063 | |
Nova Physician Group Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2000 N Main St, Waterbury, CT 06704 Phone: 203-951-8306 Fax: 475-215-3374 |